Status:
RECRUITING
Deployment o the Multidisciplinary Prospective Cohort Imminent
Lead Sponsor:
University Hospital, Lille
Collaborating Sponsors:
FHU IMMINeNT
FHU PRECISE: Projet Fédératif Hospitalo-Universitaire PREcision health in Complex Immune-mediated inflammatory diseaSEs
Conditions:
Chronic Inflammatory Disease
Angioedema
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Immune-mediated inflammatory diseases (IMIDs) most often affect young patients and have high impact on morbidity and mortality with a significant alteration in the quality of life of patients with pro...
Eligibility Criteria
Inclusion
- Patient followed for their IMID in one of the departments of the Lille University Hospital participating in the study (dermatology, internal medicine, neurology, pneumology and rheumatology)
- Social insured
- Have the capacity to understand the study requirements, provide written informed consent, and comply with the study data collection procedures.
Exclusion
- Administrative reasons: inability to receive informed information, inability to participate in the entire study, lack of coverage by the social security system.
- Pregnant or breastfeeding woman
- Persons deprived of liberty
- Protected minors or adults
- Persons who have refused or are incapable of giving informed consent
- Persons in Emergency Situations
Key Trial Info
Start Date :
July 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2031
Estimated Enrollment :
2200 Patients enrolled
Trial Details
Trial ID
NCT04334031
Start Date
July 20 2020
End Date
July 1 2031
Last Update
May 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hop Claude Huriez Chu Lille
Lille, France, 59037